Cargando…
Suppressive valacyclovir therapy to reduce genital herpes transmission: Good public health policy?
Nocturnal asthma (NA) is increasing in prevalence, affecting millions of people Genital herpes is a widespread sexually transmitted infection caused by the herpes simplex viruses (HSV). Suppressive valacyclovir therapy has been shown to significantly reduce HSV transmission. The benefits and costs o...
Autor principal: | Bonnar, Paul E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
McGill University
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687913/ https://www.ncbi.nlm.nih.gov/pubmed/19753286 |
Ejemplares similares
-
Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes
por: Martens, Mark G., et al.
Publicado: (2009) -
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir
por: Polansky, Hanan, et al.
Publicado: (2016) -
Genital Herpes Simplex Virus Type 2 Suppression With Valacyclovir Is Not Associated With Changes in Nugent Score or Absolute Abundance of Key Vaginal Bacteria
por: Babu, Tara M, et al.
Publicado: (2023) -
Efficacy of valacyclovir and famciclovir in herpes zoster: A comparative study
por: Bist, Ankita, et al.
Publicado: (2020) -
Oral Valacyclovir Treatment of Herpes Zoster Ophthalmicus-Induced Optic Neuritis
por: Hunt, Christina M, et al.
Publicado: (2021)